08.05.2014 • NewsAgricultureAgrochemistryDede Willams

U.S. EPA Seeks Comment on New Pesticide Registration

The U.S. environmental protection agency EPA has opened a public comment period on a proposed regulatory decision to register Dow Agrosciences' herbicide Enlist Duo, a proprietary mixture of 2,4-D choline and glyphosate.

The mixture, intended for use in Dow's Enlist cropping system, requires an EPA review due to the inclusion of choline form of 2,4-D used to control weeds in corn and soybeans genetically engineered (GE) to tolerate 2,4-D.  

Glyphosate is already registered and used widely. However, weeds are becoming increasingly resistant to glyphosate-based herbicides and are posing a problem for farmers.

To ensure that Enlist Duo successfully manages weed resistance problems, EPA said the proposal would impose requirements on the manufacturer, including robust monitoring and reporting, along with grower education and remediation.

The proposal also would allow EPA to take "swift action" to impose additional restrictions on Dow Agrosciences and the use of the pesticide, if resistance develops.

Public comments can be submitted up to May 30, 2014. 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.